Early Access — free while we kick the tires
EdgarHawk

Francis Hondal

Director

Director

Latest: Director buying · December 2025

2 filings analyzed · 2 companies · Latest 2026-05-21

Companies

Company Buys Sells Direction
Equitable Holdings, Inc. EQH 13 0 Net buying
Bath & Body Works, Inc. BBWI 1 0 Net buying

Activity

May 2026
medium
Buy
1,144 shares
$45,851
Significance 5/10

Director Hondal made 12 purchases totaling 1,143 shares for $45,850.53 over 22 months, blended average $40.09; stock currently $42.52, -24.9% from high.

Francis Hondal, a Director of Equitable Holdings, executed 12 separate open-market purchases over 22 months from March 2023 to December 2025, accumulating 1,143 shares at a blended average of $40.09 and increasing his holdings by 3.9% to 30,330 shares post-transaction. The purchases span a wide price range ($26.36 to $54.66), with the most recent acquisition on December 2025 at $46.86, close to the current price of $42.52. However, the company reported negative full-year net income over its most recent fiscal year and annual revenue declined 6.2%, which provides caution against inferring conviction from the consistent accumulation pattern. The stock is currently trading 24.9% below its 52-week high despite short-term strength (3.7% gain over 30 days), presenting a mixed context where persistent buying by a director is occurring against deteriorating fundamentals and elevated historical valuations.

November 2025
medium
Buy
3,343 shares
$50,128
Significance 6/10

Director Hondal Francis buys 3,343 BBWI shares at $15.00; stock down 62.1% from 52-week high, 5 other insiders bought in past 14 days.

Hondal Francis, a director of Bath & Body Works, purchased 3,343 shares at $15.00 on 2025-11-21, increasing his holdings by 18.4% to 21,554 shares. This purchase coincides with the stock trading 62.1% below its 52-week high and down 42.4% over the prior 30 days. Notably, this transaction is part of a cluster pattern with 5 other insiders also buying within the past 14 days, suggesting coordinated confidence at the current price level. However, the company's fundamentals show mixed signals: revenue of $1,594,000,000 in the latest quarter with net income of $77,000,000, but annual revenue declined 1.6% year-over-year and the stock trades at a low P/E of 4.56, indicating either distress or significant undervaluation.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access